{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:58:29Z","timestamp":1785466709074,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012910","name":"National Defense Medical College","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012910","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We report a rare case of giant hepatocellular carcinoma (HCC) with direct invasion to the colon and synchronous multiple lung metastases that achieved complete remission with surgical hepatectomy followed by chemotherapy with atezolizumab and bevacizumab. An 80-year-old man presented with abdominal distension and appetite loss. Imaging studies demonstrated a large HCC protruding from the liver with compression and invasion of the ascending colon, accompanied by multiple bilateral pulmonary nodules. To relieve symptoms and reduce the risk of tumor rupture, upfront surgical resection consisting of right hepatectomy and right hemicolectomy was performed. Histopathological examination revealed moderately to poorly differentiated HCC with direct invasion into the ascending colon and microscopic portal vein invasion. Postoperatively, tumor markers initially decreased; however, subsequent elevation led to initiation of atezolizumab plus bevacizumab for treatment of pulmonary metastases. Tumor markers subsequently normalized, and follow-up computed tomography demonstrated disappearance of all pulmonary metastases, with only scar-like lesions remaining. Radiologic complete remission was achieved 14 months after hepatectomy. The patient remains alive without recurrence 54 months after surgery. Direct invasion of HCC into adjacent organs is extremely rare and is generally associated with poor prognosis. The role of systemic chemotherapy after reduction surgery for advanced HCC remains controversial. Although this is a single case experience and caution is needed when generalizing, this case suggested that combined treatment with initial resection of the primary tumor followed by immunotherapy for remnant lesions could be feasible in selected patients and would potentially contribute to symptom relief and control of metastatic lesions.<\/jats:p>","DOI":"10.1007\/s12328-026-02360-x","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:32:17Z","timestamp":1779111137000},"page":"909-915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of complete remission of multiple lung metastases following surgical resection of huge hepatocellular carcinoma invading the colon and postoperative treatment with atezolizumab and bevacizumab"],"prefix":"10.1007","volume":"19","author":[{"given":"Mayuko","family":"Ohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8885-1210","authenticated-orcid":false,"given":"Yoji","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanae","family":"Shinada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Yonamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takazumi","family":"Tsunenari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiya","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Einama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2360_CR1","unstructured":"The Japan Society of Hepatology. JSH HCC Guidelines 2021."},{"key":"2360_CR2","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"S Richard","year":"2020","unstructured":"Richard S, Finn S, Qin M, Ikeda, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382:1894\u2013905.","journal-title":"N Engl J Med"},{"key":"2360_CR3","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382:1894\u2013905.","journal-title":"N Engl J Med"},{"key":"2360_CR4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","volume":"76","author":"AL Cheng","year":"2022","unstructured":"Cheng AL, Qin S, Ikeda M, et al. Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol. 2022;76:862\u201373.","journal-title":"J Hepatol"},{"issue":"10064","key":"2360_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","volume":"389","author":"V Arjun","year":"2017","unstructured":"Arjun V, Balar MD, Galsky, Jonathan E, Rosenberg, et al. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Lancet. 2017;389(10064):67\u201376.","journal-title":"Lancet"},{"key":"2360_CR6","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1200\/JCO.2007.15.9947","volume":"26","author":"AB Siegel","year":"2008","unstructured":"Siegel AB, Cohen EI, Ocean A, et al. Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol. 2008;26:2992\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2360_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52\u201360.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"2360_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1186\/s12885-023-11302-6","volume":"23","author":"T Masayuki Okuno","year":"2023","unstructured":"Masayuki Okuno T, Ishii A, Ichida, et al. Protocol of the RACB study: a multicenter, single-arm, prospective study to evaluate the efficacy of resection of initially unresectable hepatocellular carcinoma with atezolizumab combined with bevacizumab. BMC Cancer. 2023;23(1):780.","journal-title":"BMC Cancer"},{"issue":"6","key":"2360_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/BF00115112","volume":"14","author":"M Mitsunobu","year":"1996","unstructured":"Mitsunobu M, Toyosaka A, Oriyama T, et al. Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel. Clin Exp Metastasis. 1996;14(6):520\u20139.","journal-title":"Clin Exp Metastasis"},{"key":"2360_CR10","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1002\/cncr.25960","volume":"117","author":"K Uchino","year":"2011","unstructured":"Uchino K, Tateishi R, Shiina S, et al. Hepatocellular carcinoma with extrahepatic metastasis: Clinical features and prognostic factors. Cancer. 2011;117:4475\u201383.","journal-title":"Cancer"},{"issue":"11","key":"2360_CR11","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1111\/j.1440-1746.2005.03919.x","volume":"20","author":"T Mitsuteru Natsuizaka","year":"2005","unstructured":"Mitsuteru Natsuizaka T, Omura T, Akaike, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol. 2005;20(11):1781\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"2360_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.4103\/jcrt.JCRT_217_20","volume":"17","author":"M Mu","year":"2021","unstructured":"Mu M, Yu J, Liang P, et al. Colonic metastasis from hepatocellular carcinoma after treated by ablation and transarterial chemoembolization manifested by intestinal obstruction: a case report and review of the literature. J Cancer Res Ther. 2021;17(3):814\u20137.","journal-title":"J Cancer Res Ther"},{"key":"2360_CR13","doi-asserted-by":"crossref","unstructured":"Teijiro Hirashita M, Ohta K, Iwaki et al. Direct invasion to the colon by hepatocellular carcinoma: report of two cases. World J Gastroenterol 2008 July 28; 14(28): 4583\u20135.","DOI":"10.3748\/wjg.14.4583"},{"issue":"1","key":"2360_CR14","first-page":"91","volume":"13","author":"JH Kim","year":"2007","unstructured":"Kim JH, Park J-W, Choi J-I, et al. [Gastric metastasis of hepatocellular carcinoma treated by transarterial chemoembolization: a case report]. Korean J Hepatol. 2007;13(1):91\u20135.","journal-title":"Korean J Hepatol"},{"key":"2360_CR15","volume-title":"TNM classification of malignant tumors","author":"JG Brierley","year":"2017","unstructured":"Brierley JG, Wittekind MK, O\u2019sullivan C, et al. TNM classification of malignant tumors. 8th ed. Oxford: Wiley Blackwell; 2017.","edition":"8"},{"issue":"3","key":"2360_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/jso.20301","volume":"91","author":"A Frank","year":"2005","unstructured":"Frank A, Scappaticci L, Fehrenbacher T, Cartwright, et al. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol. 2005;91(3):173\u201380.","journal-title":"J Surg Oncol"},{"key":"2360_CR17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1440-1746.1996.tb00328.x","volume":"11","author":"M Hashimoto","year":"1996","unstructured":"Hashimoto M, Watanabe G, Matsuda M, et al. Gastrointestinal bleeding from a hepatocellular carcinoma invading the transverse colon. J Gastroenterol Hepatol. 1996;11:765\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"2360_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00004836-199707000-00019","volume":"25","author":"CY Chen","year":"1997","unstructured":"Chen CY, Lu CL, Pan CC, et al. Lower gastrointestinal bleeding from a hepatocellular carcinoma invading the colon. J Clin Gastroenterol. 1997;25:373\u20135.","journal-title":"J Clin Gastroenterol"},{"key":"2360_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1046\/j.1440-1746.2000.02152.x","volume":"15","author":"CP Lin","year":"2000","unstructured":"Lin CP, Cheng JS, Lai KH, et al. Gastrointestinal metastasis in hepatocellular carcinoma: Radiological and endoscopic studies of 11 cases. J Gastroenterol Hepatol. 2000;15:536\u201341.","journal-title":"J Gastroenterol Hepatol"},{"key":"2360_CR20","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s002610000056","volume":"25","author":"DN Srivastava","year":"2000","unstructured":"Srivastava DN, Gandhi D, Julka PK, et al. Gastrointestinal hemorrhage in hepatocellular carcinoma: Management with transheptic arterioembolization. Abdom Imaging. 2000;25:380\u20134.","journal-title":"Abdom Imaging"},{"key":"2360_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/02841850600635947","volume":"47","author":"CJ Zech","year":"2006","unstructured":"Zech CJ, Bilzer M, Mueller-Lisse UG, et al. Perforation of the colon: A rare complication of hepatocellular carcinoma. Acta Radiol. 2006;47:538\u201342.","journal-title":"Acta Radiol"},{"key":"2360_CR22","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.3748\/wjg.14.4583","volume":"14","author":"T Hirashita","year":"2008","unstructured":"Hirashita T, Ohta M, Iwaki K, et al. Direct invasion to the colon by hepatocellular carcinoma: Report of two cases. World J Gastroenterol. 2008;14:4583\u20135.","journal-title":"World J Gastroenterol"},{"key":"2360_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00004728-200201000-00014","volume":"26","author":"MS Park","year":"2002","unstructured":"Park MS, Kim KW, Yu JS, et al. Radiologic findings of gastrointestinal tract involvement in hepatocellular carcinoma. J Comput Assist Tomogr. 2002;26:95\u2013101.","journal-title":"J Comput Assist Tomogr"},{"key":"2360_CR24","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s10620-008-0273-3","volume":"53","author":"Y Nozaki","year":"2008","unstructured":"Nozaki Y, Kobayashi N, Shimamura T, et al. Colonic metastasis from hepatocellular carcinoma: Manifested by gastrointestinal bleeding. Dig Dis Sci. 2008;53:3265\u20136.","journal-title":"Dig Dis Sci"},{"key":"2360_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1177\/000313489906500306","volume":"65","author":"CA Cosenza","year":"1999","unstructured":"Cosenza CA, Sher LS, Poletti BJ, et al. Metastasis of hepatocellular carcinoma to the right colon manifested by gastrointestinal bleeding. Am Surg. 1999;65:218\u201321.","journal-title":"Am Surg"},{"key":"2360_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00432-004-0566-7","volume":"130","author":"K Inoue","year":"2004","unstructured":"Inoue K, Nakamura T, Kinoshita T, et al. Volume reduction surgery for advanced hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:362\u20136.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2360_CR27","first-page":"213","volume":"123","author":"T Daisuke Satoh","year":"2011","unstructured":"Daisuke Satoh T, Yagi H, Sadamori, et al. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic metastases: A case report. Okayama Med J. 2011;123:213\u201321.","journal-title":"Okayama Med J"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02360-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-026-02360-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02360-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:04:24Z","timestamp":1785463464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-026-02360-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2360"],"URL":"https:\/\/doi.org\/10.1007\/s12328-026-02360-x","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki.","order":2,"name":"Ethics","label":"Human and animal Rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"of 1975, as revised in 2008 (5).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient included in this study.","order":4,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}